Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Miguel Angel Fuertes"'
1
Akademický článek
Electrostatic Screening, Acidic pH and Macromolecular Crowding Increase the Self-Assembly Efficiency of the Minute Virus of Mice Capsid In Vitro
Autor: Miguel Angel Fuertes, Diego López Mateos, Luis Valiente, Alicia Rodríguez Huete, Alejandro Valbuena, Mauricio G. Mateu
Publikováno v: Viruses, Vol 15, Iss 5, p 1054 (2023)
The hollow protein capsids from a number of different viruses are being considered for multiple biomedical or nanotechnological applications. In order to improve the applied potential of a given viral capsid as a nanocarrier or nanocontainer, specifi
Externí odkaz: https://doaj.org/article/fa52155e438e4de3b10f37f2f6cbf910
Zobrazit plný text záznamu
3
Akademický článek
Improvement of attitudes and skills using a MOOC about the basic science of climate change
Autor: Enzo Ferrari, Anne-Marie Ballegeer, Diego Corrochano, Miguel Ángel Fuertes, Pablo Herrero Teijón, María Laura Delgado Martín, Santiago Andrés Sánchez, Camilo Ruiz
Publikováno v: Humanities & Social Sciences Communications, Vol 11, Iss 1, Pp 1-12 (2024)
Abstract Education needs to be at the forefront of the efforts to mitigate and adapt to Climate Change (CC) effects. We have introduced the Climate Change Competence (C3) to provide a comprehensive route to include the topics of sustainability and CC
Externí odkaz: https://doaj.org/article/5d13fa7a33694cdd8b9305e5368bd126
Zobrazit plný text záznamu
4
A Genetically Engineered, Chain Mail-Like Nanostructured Protein Material with Increased Fatigue Resistance and Enhanced Self-Healing
Autor: Santos Domínguez‐Zotes, Miguel Angel Fuertes, Alicia Rodríguez‐Huete, Alejandro Valbuena, Mauricio G Mateu
Publikováno v: Small (Weinheim an der Bergstrasse, Germany). 18(11)
Protein-based nanostructured materials are being developed for many biomedical and nanotechnological applications. Despite their many desirable features, protein materials are highly susceptible to disruption by mechanical stress and fatigue. This st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f60f1112f0edaebd1d479cfb760568
https://pubmed.ncbi.nlm.nih.gov/35060301
Zobrazit plný text záznamu
5
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Autor: María Perera, Montserrat Cortés, Erika Coria, Miguel Angel Fuertes-Palacio, Laura Solán, Isabel Caparrós, Inés Valcarce, Isidro Jarque, Carlos Aguilar, R. Jiménez, Pilar Galan, Silvia Bernat, Tomás José González-López, Pável E Olivera, Mónica Martín-Salces, Adriana Sainz, María Carmen Arratibel, María Paz Martínez-Badas, Maria Eva Mingot-Castellano, Manuel González-Silva, Fernando Fernández-Fuertes, Rafael Feito Alonso, Erik de Cabo, Juan Andrés Vázquez-Paganini, Angeles Fernández-Rodríguez, Susana Pérez-Crespo, Paola Beneit, Carmen Fernández-Miñano, Rosa Fisac, Carmen de Cos, Maria José Cortti, Violeta Martínez-Robles, Jose Angel Hernandez-Rivas, Alberto Casaus, Armando Luaña, Isabel Gutierrez-Jomarrón, Arancha Alonso, Cristina Fernández-Canal, María Teresa Álvarez-Román, María Jesús Peñarrubia, Javier García-Frade, Marcio M Andrade, José Ramón González-Porras, Marta Gómez-Nuñez, María Calbacho, Gloria Pérez-Rus, Cristina Pascual, Blanca Sanchez-Gonzalez
Publikováno v: American Journal of Hematology. 90:E40-E43
Eltrombopag is effective and safe in immune thrombocytopenia (ITP). Some patients may sustain their platelet response when treatment is withdrawn but the frequency of this phenomenon is unknown. We retrospectively evaluated 260 adult primary ITP pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51bdd0e8fe6218ff5b4f6f1ed793dbab
https://doi.org/10.1002/ajh.23900
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje